Takahiro Horie

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

PloS one

European heart journal. Cardiovascular pharmacotherapy

Nature communications

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Takahiro Horie, Koh Ono
VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. European heart journal. Cardiovascular pharmacotherapy 10 (2) (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Takahiro Horie, Koh Ono
VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. European heart journal. Cardiovascular pharmacotherapy (2023)
Sawa Miyagawa, Takahiro Horie, Tomohiro Nishino, Satoshi Koyama, Toshimitsu Watanabe, Osamu Baba, Tomohiro Yamasaki, Naoya Sowa, Chiharu Otani, Kazuki Matsushita, Hidenori Kojima, Masahiro Kimura, Yasuhiro Nakashima, Satoshi Obika, Yusuke Tamenori, Jun Kotera, Kozo Oka, Ryo Fujita, Takashi Sasaki, Akihiro Takemiya, Koji Hasegawa, Takeshi Kimura, Koh Ono
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis. Life science alliance 6 (8) (2023)
Takahiro Horie, Tetsushi Nakao, Yui Miyasaka, Tomohiro Nishino, Shigenobu Matsumura, Fumiko Nakazeki, Yuya Ide, Masahiro Kimura, Shuhei Tsuji, Randolph Ruiz Rodriguez, Toshimitsu Watanabe, Tomohiro Yamasaki, Sijia Xu, Chiharu Otani, Sawa Miyagawa, Kazuki Matsushita, Naoya Sowa, Aoi Omori, Jin Tanaka, Chika Nishimura, Masataka Nishiga, Yasuhide Kuwabara, Osamu Baba, Shin Watanabe, Hitoo Nishi, Yasuhiro Nakashima, Marina R Picciotto, Haruhisa Inoue, Dai Watanabe, Kazuhiro Nakamura, Tsutomu Sasaki, Takeshi Kimura, Koh Ono
microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity. Nature communications 12 (1) (2021)
Koh Ono, Takahiro Horie, Osamu Baba, Masahiro Kimura, Shuhei Tsuji, Randolph Ruiz Rodriguez, Sawa Miyagawa, Takeshi Kimura
Functional non-coding RNAs in vascular diseases. The FEBS journal 288 (22) (2021)
Yasuhide Kuwabara, Shuhei Tsuji, Masataka Nishiga, Masayasu Izuhara, Shinji Ito, Kazuya Nagao, Takahiro Horie, Shin Watanabe, Satoshi Koyama, Hisanori Kiryu, Yasuhiro Nakashima, Osamu Baba, Tetsushi Nakao, Tomohiro Nishino, Naoya Sowa, Yui Miyasaka, Takeshi Hatani, Yuya Ide, Fumiko Nakazeki, Masahiro Kimura, Yoshinori Yoshida, Tsukasa Inada, Takeshi Kimura, Koh Ono
Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload. Communications biology 3 (1) (2020)

Takahiro Horie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takahiro Horie